Stanford B型主动脉夹层的诊疗进展

doi:10.6040/j.issn.1671-7554.0.2024.0448

摘要/Abstract

摘要： 近年来随着对疾病理解的加深,Stanford B型主动脉夹层的诊疗取得了长足的进步。一方面,对夹层的分类更加精细化,从而能够更好地指导临床诊疗;另一方面,新型影像学检查和生物标志物的发现,有助于进一步提升夹层诊断的准确率。治疗方面,伴随着腔内技术的快速发展,Stanford B型主动脉夹层的治疗趋于微创化,且治疗效果也拾级而上。而累及弓上或内脏区夹层病变的微创治疗是当下的诊疗热点,涌现出了许多新方法和新器具,有望进一步改善临床诊疗的效果。

关键词: Stanford B型主动脉夹层, 胸主动脉腔内修复术, 夹层分类, 非A非B型夹层

Abstract: The diagnosis and treatment of Stanford type B aortic dissection(TBAD)has been greatly improved in recent years due to a better understanding of the disease. On one hand, the classification of TBAD has been more refined, thus enabling better guidance for AD diagnosis and treatment. On the other hand, the using of new imaging tests and biomarkers has helped to further improve the accuracy of AD diagnosis. In terms of treatment, along with the rapid development of endovascular technology, the treatment of TBAD tends to be minimally invasive, and the result is also significantly improved. Endovascular therapy of TBAD involving aortic arch or visceral areas is a hot topic nowadays, and many new methods and devices have emerged in this areas, which are expected to further improve the clinical outcome.

Key words: Stanford type B aortic dissection, Thoracic endovacular aortic repair, Dissection classification, Non-A non-B aortic dissection

中图分类号:

R654.3

林长泼,符伟国. Stanford B型主动脉夹层的诊疗进展[J]. 山东大学学报 (医学版), 2024, 62(9): 7-12.

LIN Changpo, FU Weiguo. Progress in diagnosis and treatment of Stanford type B aortic dissection[J]. Journal of Shandong University (Health Sciences), 2024, 62(9): 7-12.

参考文献

[1] Gouveia e Melo R, Mourão M, Caldeira D, et al. A systematic review and meta-analysis of the incidence of acute aortic dissections in population-based studies[J]. J Vasc Surg, 2022, 75(2): 709-720.
[2] Tang X, Lu K, Liu XF, et al. Incidence and survival of aortic dissection in urban China: results from the national insurance claims for epidemiological research(NICER)study[J]. Lancet Reg Health West Pac, 2021, 17: 100280. doi:10.1016/j.lanwpc.2021.100280.
[3] Pape LA, Awais M, Woznicki EM, et al. Presentation, diagnosis, and outcomes of acute aortic dissection: 17-year trends from the international registry of acute aortic dissection[J]. J Am Coll Cardiol, 2015, 66(4): 350-358.
[4] Howard C, Ponnapalli A, Shaikh S, et al. Non-a non-B aortic dissection: a literature review[J]. J Card Surg, 2021, 36(5): 1806-1813.
[5] Sievers HH, Rylski B, Czerny M, et al. Aortic dissection reconsidered: type, entry site, malperfusion classification adding clarity and enabling outcome prediction[J]. Interact Cardiovasc Thorac Surg, 2020, 30(3): 451-457.
[6] Lombardi JV, Hughes GC, Appoo JJ, et al. Society for Vascular Surgery(SVS)and Society of Thoracic Surgeons(STS)reporting standards for type B aortic dissections[J]. J Vasc Surg, 2020, 71(3): 723-747.
[7] Ge YY, Rong D, Ge XH, et al. The 301 classification: a proposed modification to the stanford type B aortic dissection classification for thoracic endovascular aortic repair prognostication[J]. Mayo Clin Proc, 2020, 95(7): 1329-1341.
[8] Wang Y, Tan X, Gao H, et al. Magnitude of soluble ST2 as a novel biomarker for acute aortic dissection[J]. Circulation, 2018, 137(3): 259-269.
[9] König KC, Lahm H, Dreßen M, et al. Aggrecan: a new biomarker for acute type A aortic dissection[J]. Sci Rep, 2021, 11(1): 10371. doi:10.1038/s41598-021-89653-y.
[10] Forrer A, Schoenrath F, Torzewski M, et al. Novel blood biomarkers for a diagnostic workup of acute aortic dissection[J]. Diagnostics, 2021, 11(4): 615. doi:10.3390/diagnostics11040615.
[11] 中华医学会外科学分会血管外科学组. Stanford B型主动脉夹层诊断和治疗中国专家共识(2022版)[J]. 中国血管外科杂志(电子版), 2022, 14(2): 119-130.
[12] 中华医学会心血管病学分会大血管学组,中国医师协会心血管内科医师分会指南与共识工作委员会. 胸主动脉腔内治疗围手术期管理中国专家共识[J]. 中华医学杂志, 2019, 99(32): 2489-2496.
[13] Suzuki T, Isselbacher EM, Nienaber CA. Type-selective benefits of medications in treatment of acute aortic dissection(from the international registry of acute aortic dissection[IRAD] )[J]. J Vasc Surg, 2012, 55(4): 1220-1221.
[14] Jonker FHW, Trimarchi S, Rampoldi V, et al. Aortic expansion after acute type B aortic dissection[J]. Ann Thorac Surg, 2012, 94(4): 1223-1229.
[15] Nienaber CA, Rousseau H, Eggebrecht H, et al. Randomized comparison of strategies for type B aortic dissection: the INvestigation of STEnt Grafts in Aortic Dissection(INSTEAD)trial[J]. Circulation, 2009, 120(25): 2519-2528.
[16] Nienaber CA, Kische S, Rousseau H, et al. Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial[J]. Circ Cardiovasc Interv, 2013, 6(4): 407-416.
[17] Brunkwall J, Kasprzak P, Verhoeven E, et al. Endovascular repair of acute uncomplicated aortic type B dissection promotes aortic remodelling: 1 year results of the ADSORB trial[J]. Eur J Vasc Endovasc Surg, 2014, 48(3): 285-291.
[18] Wang J, Jin T, Chen B, et al. Systematic review and meta-analysis of current evidence in endograft therapy vs medical treatment for uncomplicated type B aortic dissection[J]. J Vasc Surg, 2022, 76(4): 1099-1108.
[19] Torrent DJ, McFarland GE, Wang G, et al. Timing of thoracic endovascular aortic repair for uncomplicated acute type B aortic dissection and the association with complications[J]. J Vasc Surg, 2021, 73(3): 826-835.
[20] Ma T, Dong ZH, Fu WG, et al. Incidence and risk factors for retrograde type A dissection and stent graft-induced new entry after thoracic endovascular aortic repair[J]. J Vasc Surg, 2018, 67(4): 1026-1033.
[21] Miyairi T, Miyata H, Chiba K, et al. Influence of timing after thoracic endovascular aortic repair for acute type B aortic dissection[J]. Ann Thorac Surg, 2018, 105(5): 1392-1396.
[22] Isselbacher EM, Preventza O, Hamilton Black J 3rd, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American heart association/american college of cardiology joint committee on clinical practice guidelines[J]. Circulation, 2022, 146(24): e334-e482. doi:10.1161/CIR.0000000000001106.
[23] Rudarakanchana N, Jenkins MP. Hybrid and total endovascular repair of the aortic arch[J]. Br J Surg, 2018, 105(4): 315-327.
[24] Li Y, He CS, Chen X, et al. Endovascular in situ fenestration technique of aortic arch pathology: a systematic review and meta-analysis[J]. Ann Vasc Surg, 2021, 76: 472-480. doi:10.1016/j.avsg.2020.12.021.
[25] Zhu JC, Zhao LJ, Dai XC, et al. Fenestrated thoracic endovascular aortic repair using physician modified stent grafts for acute type B aortic dissection with unfavourable landing zone[J]. Eur J Vasc Endovasc Surg, 2018, 55(2): 170-176.
[26] 胡凡果, 朱杰昌, 戴向晨, 等. 体外预开窗腔内修复治疗非健康锚定区及短锚定区B型主动脉夹层的前瞻性单中心研究[J]. 中华普通外科杂志, 2020, 35(7): 536-539. HU Fanguo, ZHU Jiechang, DAI Xiangchen, et al. The treatment of Stanford type B aortic dissection with unhealthy or short anchoring zone using physician-modified fenestration TEVAR[J]. China Journal of General Surgery, 2020, 35(7): 536-539.
[27] Zhu JC, Ma C, Dai XC, et al. Outcomes of single physician-modified fenestrated stent grafts for endovascular repair of thoracic aortic lesions involving the distal aortic arch[J]. Interact Cardiovasc Thorac Surg, 2021, 32(4): 560-565.
[28] Jayet J, Heim F, Coggia M, et al. An Experimental Study of Laser in situ Fenestration of Current Aortic Endografts[J]. Eur J Vasc Endovasc Surg, 2018, 56(1): 68-77.
[29] Wang XH, Zhu QQ, He YY, et al. Mid-term outcomes of physician-modified fenestrated or branched endovascular repair for post-dissection thoracoabdominal aortic aneurysms[J]. Cardiovascular Intervent Radiol, 2022, 45(11): 1672-1681.
[30] Wang RH, Kan YQ, Yang M, et al. Clinical results and aortic remodeling after endovascular treatment for complicated type B aortic dissection with the “fabulous” stent system[J]. Front Cardiovasc Med, 2022, 9: 817675. doi:10.3389/fcvm.2022.817675.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed